C
Penumbra, Inc. PEN
$268.79 $0.5850.22%
Recommendation
Hold
Prev Close
$268.20
Volume
18,753
Avg Vol (90D)
370,429
Market Cap
$10.29B
Dividend & Yield
--
52-Week Range
$148.00 - $277.34
P/E (TTM)
313.17
EPS (TTM)
$0.8564
My Lists My Alerts
Rating
Reward
B-
Good
Risk
D
Weak
Rating Factors
Growth Index
Excellent
Efficiency Index
Fair
Solvency Index
Excellent
Total Return Index
Fair
Volatility Index
Weak
Dividend Index
--
Headlines
Charles River Launches Apollo for CRADL to Boost Research, Stock Rises
1/22/2025 - Zacks Investment Research
UBS Group Begins Coverage on Penumbra (NYSE:PEN)
1/22/2025 - Ticker Report
Penumbra Inc (PEN) Announces Fourth Quarter and Full Year 2024 Earnings Call
1/21/2025 - GuruFocus
Penumbra, Inc. Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call ...
1/21/2025 - GuruFocus
Penumbra, Inc. Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call for February 18, 2025
1/21/2025 - PR Newswire
Penumbra started at buy by UBS on growth potential
1/21/2025 - Seeking Alpha - Healthcare
10 Analysts Assess Penumbra: What You Need To Know
1/21/2025 - Benzinga
Penumbra (NYSE:PEN) Earns Buy Rating from Analysts at UBS Group
1/21/2025 - MarketBeat
Penumbra initiated with a Buy at UBS
1/21/2025 - TipRanks Financial Blog
Penumbra initiated with bullish view at UBS, here's why
1/21/2025 - The Fly
Peering Into Penumbra's Recent Short Interest
1/20/2025 - Benzinga
Completion of Whole Blood Assets Sale to GVS Likely to Boost HAE Stock
1/20/2025 - Zacks Investment Research
Buy 4 Low-Beta Stocks AVO, TXO, PEN & STRA to Beat Market Volatility
1/17/2025 - Zacks Investment Research
Will CRL Stock Gain From Integration of Akron Bio's CSS Product Line?
1/17/2025 - Zacks Investment Research
3 Reasons Why Growth Investors Shouldn't Overlook Penumbra (PEN)
1/16/2025 - Zacks Investment Research
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
1/16/2025 - Zacks Investment Research
Illumina Partners NVIDIA for Genomic Advancements, ILMN Stock Climbs
1/16/2025 - Zacks Investment Research
Pallas Capital Advisors LLC Raises Stake in Penumbra, Inc. (NYSE:PEN)
1/16/2025 - Ticker Report
Zacks.com featured highlights YPF Sociedad, Telefonica, Penumbra, Deckers Outdoor and Abercrombie & Fitch
1/16/2025 - Zacks Investment Research
5 Must-Buy Efficient Stocks to Increase Your Portfolio Returns
1/15/2025 - Zacks Investment Research
AxoGen, Inc. (AXGN) Soars to 52-Week High, Time to Cash Out?
1/13/2025 - Zacks Investment Research
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
1/9/2025 - Zacks Investment Research
Penumbra (PEN, $257.81) Moving Average Convergence Divergence (MACD) Histogram turned positive on January 8, 2025
1/9/2025 - Tickeron - Stocks
ILMN Stock Set to Gain From Latest Updates to the NovaSeq X Series
1/8/2025 - Zacks Investment Research
Penumbra (PEN) Surges 6.3%: Is This an Indication of Further Gains?
1/8/2025 - Zacks Investment Research
Income Statement
Total Revenue (TTM)
$1.16B
EBITDA (TTM)
$102.53M
EBIT (TTM)
$78.48M
Net Income (TTM)
$34.55M
Balance Sheet
Total Assets (Q)
$1.48B
Total Debt (Q)
$226.69M
Total Liabilities (Q)
$374.84M
Book Value Per Share (Q)
$28.78
Cash Flow
Cash from Operations (TTM)
$153.63M
Cash from Investing (TTM)
$112.86M
Cash from Financing (TTM)
-$87.15M
Net Change in Cash (TTM)
$179.72M
Filings
Filing Date
Wednesday, October 30, 2024
Period Date
Monday, September 30, 2024
Next Filing
Week of Feb 17 and 21 (est)
Price History
Loading...
Beta
0.95
7-Day Total Return
7.25%
30-Day Total Return
10.75%
60-Day Total Return
31.94%
90-Day Total Return
32.86%
Year to Date Total Return
12.00%
1-Year Total Return
6.35%
2-Year Total Return
7.24%
3-Year Total Return
17.65%
5-Year Total Return
57.56%
52-week Low
Jul 31, 2024 - $148.00
52-week High
Feb 16, 2024 - $277.34
Valuation
Market Cap
$10.29B - Large Cap
Enterprise Value
$10.23B
Price/Sales (TTM)
9.03
Price/Book (Q)
9.32
Dividends and Shares
Shares Outstanding
39.18M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.penumbrainc.com
Phone Number
510 748 3200
Address
One Penumbra Place
Alameda, CA 94502
Country
United States
Year Founded
2004
Business Description
Sector
Health Care
Industry
Health Care Equipment and Services
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products... more
NYSE 01/22/2025 10:09AM Eastern Quotes delayed
Weiss Ratings